Philippe-Alexandre Gilbert

Dr. Philippe-Alexandre Gilbert is an experienced bioprocess engineer with a 20-years track record of success in propelling breakthrough process improvements for biotech industries in Canada, US and Europe.  As Senior Program Officer of the Bill and Melinda Gates Foundation, Dr. Gilbert is responsible for implementing technical solutions that speed and de-risk the development of appropriate vaccine candidates for global health needs. He has previously served as the COVID 19 CMC lead on emergency assignment with Sanofi Pasteur where he also has served as the Head Flu New Technology leader and previously Senior Director of Manufacturing Technology (2015-2020). In addition, he has served as the Head of Upstream Development with Novartis Vaccines and Diagnostics (2013-2015) as well as Assistant Director / Senior Manager with GlaxoSmithKline Vaccines (2011-2013). From 2008-2011 he served as the Senior Scientist and Group Leader for the Vaccine Section of Medimmune and developed the Flu mist Technology with the first swine flu H1N1 vaccine on the market. He is an expert in vaccine production systems, process design, cost-reduction strategies, disposable process and quality by design processes. He is known for innovative problem solving, complex troubleshooting and skillful relationship-building with cross-functional teams and industrial partners. Dr. Gilbert received his PhD in Biochemical Engineering and Masters in Molecular Biology from Laval University in Quebec, Canada.